Carregant...
Successful Primary Medical Therapy with Somatostatin Receptor Ligand in Acromegaly with Thyroid Cancer
Acromegaly is a rare disease with an annual incidence of 3 to 4 cases in a million.(1) Diagnosis is often delayed due to the slow progression of the disease. Persistent elevation of growth hormone (GH) in acromegaly causes a reduction in life expectancy by 10 years. Aside from multiple cardiovascula...
Guardat en:
| Publicat a: | J ASEAN Fed Endocr Soc |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Journal of the ASEAN Federation of Endocrine Societies
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784230/ https://ncbi.nlm.nih.gov/pubmed/33442102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15605/jafes.032.02.12 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|